Abstract:Objective To evaluate the role of monocyte chemotactic factor-1 (MCP-1)∕chemokine C-C receptor 2 ( CCR2) in amygdala in neuropathic pain ( NP) in rats. Methods Clean-grade healthy male Sprague-Dawley rats, weighing 200-260 g, aged 2 months, in which NP model was established by ligating the left L5,6spinal nerve, were used in this study. The experiment was performed in two parts. Ex-periment Ⅰ Thirty-two rats were divided into 2 groups using a random number table method: control group (C group, n＝8) and NP group (n＝24). Rats were sacrificed at 7, 14 and 21 days after establis-hing NP model in group NP or at the corresponding time points before establishing NP model in group C, and the amygdala was removed for determination of the expression of MCP-1 and CCR2 mRNA and positive cell count using quantitative real-time polymerase chain reaction and immunohistochemistry. Experiment ⅡThirty-two rats were divided into 4 groups ( n＝8 each) using a random number table method: control group (C group), NP group, MCP-1 group and specific CCR2 antagonist RS102895 group (RS group). MCP-1 (50 pmol for each side) or RS102895 (100 pmol for each side) was injected into the bilateral a-mygdala at days 3, 6, 13 and 20 after establishing NP model in MCP-1 and RS groups, respectively. The thermal paw withdrawal latency (TWL) and mechanical paw withdrawal threshold (MWT) were measured at days 4, 7, 14 and 21 after establishing NP model (T1-4). Rats were sacrificed at T4and the L5segment of the spinal cord was removed for determination of interleukin-1beta (IL-1β), IL-6 and tumor necrosis fac-tor-alpha ( TNF-α) contents by enzyme-linked immunosorbent assay. Results Experiment Ⅰ Compared with group C, the expression of MCP-1 and CCR2 mRNA in amygdala was significantly up-regulated, and the number of MCP-1 and CCR2 positive cells was increased in group NP ( P＜0. 05). Experiment ⅡCompared with group C, the MWT was significantly decreased and TWL was shortened at T1-4, and the contents of IL-1β, IL-6 and TNF-α were increased in the other three groups ( P＜0. 05). Compared with group NP, the MWT was significantly decreased and TWL was shortened at T1, and the contents of IL-1β, IL-6 and TNF-α were increased in group MCP-1, and the MWT was significantly increased and TWL was prolonged at T1-4, and the contents of IL-1β, IL-6 and TNF-α were decreased in group RS ( P＜0. 05 or 0. 01). Conclusion Enhanced function of MCP-1∕CCR2 in amygdala may be involved in the pathophysio-logical process of NP in rats.

Role of Neurite Outgrowth Inhibitor-a and Calcitonin Gene Related Peptide 1 Receptor in Pain Modulation in Nucleus Accumbens of Rats with Inflammatory Pain

The Involvement of Spinal Annexin A10/NF-κB/MMP-9 Pathway in the Development of Neuropathic Pain in Rats

Correction: Divergent Modulation of Pain and Anxiety by GABAergic Neurons in the Ventrolateral Periaqueductal Gray and Dorsal Raphe.

Role of Calcitonin Gene-Related Peptide in Nociceptive Modulationin Anterior Cingulate Cortex of Naive Rats and Rats With Inflammatory Pain

Calcitonin Gene-Related Peptide and Its Receptor Plays Important Role in Nociceptive Regulation in the Arcuate Nucleus of Hypothalamus of Rats with Inflammatory Pain.

Involvement of Opioid Receptors in the CGRP-induced Antinociception in the Nucleus Accumbens of Rats

Involvement of CGRP and CGRP1 receptor in nociception in the nucleus accumbens of rats.

Involvement of CGRP and CGRP Receptor in Nociceptive Modulation in Arcuate Nucleus of the Hypothalamus in Rats with Neuropathic Pain

[EXPRESS] Chronic Inflammatory Pain Decreases the Glutamate Vesicles in Presynaptic Terminals of the Nucleus Accumbens.

Role of Monocyte Chemoattractant Factor∕chemokine C-C Receptor 2 Pathway in Amygdala in Neuro-Pathic Pain in Rats

Anti-Nociceptive Role of Neuropeptide Y in the Nucleus Accumbens in Rats with Inflammation, an Effect Modulated by Mu- and Kappa-Opioid Receptors

Role of calcitonin gene-related peptide in pain regulation in the parabrachial nucleus of naive rats and rats with neuropathic pain

Anti-nociceptive effects of calcitonin gene-related peptide in nucleus raphe magnus of rats: an effect attenuated by naloxone.

Effect of Intrathecal Sufentanil and Protein Kinase C Inhibitor on Pain Threshold and the Expression of NMDA Receptor/cgrp in Spinal Dorsal Horn in Rats with Neuropathic Pain

Inhibition of Inflammatory Pain by Activating B-Type Natriuretic Peptide Signal Pathway in Nociceptive Sensory Neurons

Effect of Intrathecal Administration of Exogenous Noggin on Neuropathic Pain.

Calcineurin in Inflammatory Pain Induced by Complete Freund′s Adjuvant in Rats

Upregulation of Tumor Necrosis Factor-Alpha in Nucleus Accumbens Attenuates Morphine-Induced Rewarding in a Neuropathic Pain Model.

Role of Glycogen Synthase Kinase-3Β in Trafficking of NR1-containing N-methyl-D-aspartate Receptor and NR2B-containing N-methyl-D-aspartate Receptor in Spinal Cord in Rats with Incisional Pain and Remifentanil-Induced Hyperalgesia

Involvement of neuropeptide Y and Y1 receptor in antinociception in the arcuate nucleus of hypothalamus, an immunohistochemical and pharmacological study in intact rats and rats with inflammation.

Activation of the N-methyl-D-aspartate receptor and calcium/calmodulin-dependent protein kinase IIα signal in the rostral anterior cingulate cortex is involved in pain-related aversion in rats with peripheral nerve injury